Previous 10 | Next 10 |
DBV Technologies press release (NASDAQ:DBVT): FY GAAP EPS of -$1.78 beats by $0.28. Revenue of $5.70M (-49.5% Y/Y) beats by $0.83M. For further details see: DBV Technologies GAAP EPS of -$1.78 beats by $0.28, revenue of $5.70M beats by $0.83M
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates m VP Pivotal Protocol Complete and Ready for Submission to FDA DBV Continues to E ngage in Productive Exchanges with FDA Cash ...
Gainers: Indonesia (NYSE:INDO) +60%. Tonix Pharmaceutical (NASDAQ:TNXP) +51%. Eos Energy Enterprises (NASDAQ:EOSE) +33%. Rimini Street (NASDAQ:RMNI) +30%. KLX Energy Services (NASDAQ:KLXE) +18%. DBV Technologies (NASDAQ:DBVT) +17%. Barrett Business Services (NASDAQ:BBSI) +16%. Ferroglobe (NAS...
Gainers: DBV Technologies (NASDAQ:DBVT) +16%. EyePoint Pharmaceuticals (NASDAQ:EYPT) +14%. Antares Pharma (NASDAQ:ATRS) +10%. Nuvalent (NASDAQ:NUVL) +8%. Aquestive Therapeutics (NASDAQ:AQST) +7%. Losers: NuCana (NASDAQ:NCNA) -54%. MediWound (NASDAQ:MDWD) -15%....
Indonesia Energy (NYSE:INDO) +46%. Imperial Petroleum (NASDAQ:IMPP) +20%. DBV Technologies (NASDAQ:DBVT) +19%. Canaan (NASDAQ:CAN) +18% on Q4 results. Cedar Realty (NYSE:CDR) +14% on acquisition by Wheeler REIT. Eos Energy (NASDAQ:EOSE) +14%. Wheeler Real Estate (NASDAQ:WH...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! In preparation for another busy day of trading, we’ve put together a list of the biggest pre-market stock movers for Thursday! Source: ventdusud / Shutterstock.com We’ve got ear...
DBV Technologies (NASDAQ:DBVT) is scheduled to announce FY earnings results on Thursday, March 3rd, after market close. The consensus EPS Estimate is -$0.48 (+83.7% Y/Y) and the consensus Revenue Estimate is $4.87M (-56.8% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisio...
ACR, AQN, AVAV, AVGO, BCEL, CEMI, CLLS, CLXT, COO, COST, OTCPK:CURLF, DBVT, DUOL, EGLE, ENVX, EOLS, ESTC, EVFM, FCRD, FDUS, FNKO, GPS, INMB, OTCPK:MEGEF, MRVL, NCMI, ONCY, PAYO, PBYI, SIGA, SWBI, VERI, VZIO For Seeking Alpha's full earnings season calendar, click here. For further details s...
Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmac...
Montrouge, France, February 22, 2022 DBV Technologies to Participate in Upcoming AAAAI 202 2 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced ...
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...